More Globe Newswire

View Older Stories View Newer Stories

Feb 9, 2026 07:30AM BioSyent to Acquire Oral Science Inc.
Feb 9, 2026 07:30AM FG Nexus Announces 1-for-5 Reverse Stock Split
Feb 9, 2026 07:30AM Abaxx Exchange Partners with ipushpull to Deliver Real-Time Market Data Directly into Microsoft Excel
Feb 9, 2026 07:30AM Sleep experts urge adoption of permanent standard time to protect public health as Americans prepare to ‘spring forward’
Feb 9, 2026 07:30AM Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update
Feb 9, 2026 07:30AM Context Therapeutics to Participate in Upcoming Investor Conferences
Feb 9, 2026 07:28AM Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease
Feb 9, 2026 07:22AM Jeffs’ Brands: KeepZone AI Enters Into Anti-Submarine and Underwater Security Systems with Strategic Agreement
Feb 9, 2026 07:20AM WISDOMTREE NATURAL GAS 3x DAILY LEVERAGED SECURITIES NOTICE OF ADJOURNMENT OF MEETING
Feb 9, 2026 07:16AM Novo Nordisk A/S - share repurchase programme
Feb 9, 2026 07:16AM Digitally Engineered Precision: Professor John A. Sorensen Unveils Complex Full-Arch Implant Case Featuring Besmile’s Advanced Workflow
Feb 9, 2026 07:15AM BeyondSpring to Participate at the 12th Annual Immuno-Oncology 360° Conference
Feb 9, 2026 07:07AM Memo Therapeutics AG Enters into a Collaboration and Option Agreement with CSL for Development of Recombinant Polyclonal IgG Technology
Feb 9, 2026 07:05AM Kraig Biocraft Laboratories Poised for Explosive Spider Silk Production Growth
Feb 9, 2026 07:05AM Outdoor Holding Company Reports Continued Profitability In Third Quarter Fiscal 2026
Feb 9, 2026 07:05AM Zenas BioPharma Announces Late-Breaking Platform Presentation of Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis at ACTRIMS Forum 2026
Feb 9, 2026 07:04AM Form 8.3 - Picton Property Income Limited
Feb 9, 2026 07:03AM Vitalist and MicroEJ Partner with BENIO to Launch First VitalOS™ Powered Smartwatch in Asia
Feb 9, 2026 07:02AM Ocugen Appoints Rita Johnson-Greene to Chief Financial Officer
Feb 9, 2026 07:01AM Form 8.3 - Bluefield Solar Income Fund Ltd
Feb 9, 2026 07:00AM Maxim Power Corp. enters into a Gas Turbine and Generator Reservation Agreement and provides Prairie Lights Power Project Update
Feb 9, 2026 07:00AM Itafos Files Technical Report for Updated Preliminary Economic Assessment for the Arraias Phosphate Project
Feb 9, 2026 07:00AM Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update
Feb 9, 2026 07:00AM ValOre Approves Phase 2 of Metallurgical Testwork for Pedra Branca PGE project in Brazil: Program Underway in Partnership with the University of Cape Town Department of Chemical Engineering
Feb 9, 2026 07:00AM Freehand Debuts as New Company with Dedicated AI Teams for Supply Chain Spend Management
Feb 9, 2026 07:00AM Emerita Intersects 9.2m Grading 1.4% Copper, 0.4% Lead, 1.3% Zinc, 0.41 g/t Gold and 21.48 g/t Silver at El Cura
Feb 9, 2026 07:00AM Westhaven Lists on the OTCQB Venture Market
Feb 9, 2026 07:00AM Media Advisory: Wear Red Canada highlights heart disease crisis facing Canadian women
Feb 9, 2026 07:00AM Volatus Secures Drone Training Contract with NATO Defence Partner
Feb 9, 2026 07:00AM Ashland agrimer™ eco-coat polymer seed coating from the Transformed Vegetable Oils (TVO) platform receives approval for all food and non-food uses in pesticide formulations including for sale in the
Feb 9, 2026 07:00AM SparingVision Successfully Completes PRODYGY Trial Patient Dosing with SPVN06, its Novel Neuroprotective Gene Therapy
Feb 9, 2026 07:00AM Inspira Secures Vendor Approval from $12 Billion Revenue HMO (World’s 2nd Largest), Enabling Immediate ART100 Deployment
Feb 9, 2026 07:00AM Can-Fite: Receives Canadian Patent Allowance for Namodenoson as an Anti-Obesity Therapy
Feb 9, 2026 07:00AM Astera Labs Expands Global Footprint with New Israel Design Center to Support Growing Demand for AI Connectivity Solutions
Feb 9, 2026 07:00AM Talisker Intersects 52.2 g/t Au over 0.55 metres, within 19.15 g/t over 1.60 metres, from the 2025 Bralorne Gold Project Resource Conversion Program
Feb 9, 2026 07:00AM Osisko Development Awards Project and Construction Management Services Contract for the Development of the Cariboo Gold Project
Feb 9, 2026 07:00AM Oruka Therapeutics to Participate in Multiple Upcoming Conferences
Feb 9, 2026 07:00AM NervGen Pharma Appoints Adam Rogers as Chief Executive Officer to Continue Leading the Company’s Growth and Execution of Its Mission in Spinal Cord Injury
Feb 9, 2026 07:00AM First Intervention Shown to Lower Alzheimer’s and Dementia Incidence
Feb 9, 2026 07:00AM GXO Announces Formation of Defense Advisory Board
Feb 9, 2026 07:00AM Ashland agrimer™ eco-coat polymer seed coating from the Transformed Vegetable Oils (TVO) platform receives approval for all food and non-food uses in pesticide formulations including for sale in the
Feb 9, 2026 07:00AM Hain Celestial Reports Fiscal Second Quarter 2026 Financial Results
Feb 9, 2026 07:00AM Sportradar to Power NBA Fan Experiences Across NBC Sports Regional Sports Networks through Advanced Data and Enhanced Visual Storytelling
Feb 9, 2026 07:00AM Swvl Secures a New Up to $1.5 Million Multi-Year Contract in Saudi Arabia, Expanding Its Healthcare Mobility Footprint Across the GCC
Feb 9, 2026 07:00AM STUDY BY RAMSEY SOLUTIONS FINDS AMERICANS PREFER FINANCIAL STABILITY OVER EXCITEMENT IN A PARTNER
Feb 9, 2026 06:59AM Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knock-off Wegovy® and Ozempic®
Feb 9, 2026 07:00AM SparingVision Successfully Completes PRODYGY Trial Patient Dosing with SPVN06, its Novel Neuroprotective Gene Therapy
Feb 9, 2026 07:00AM Schouw & Co. share buy-back programme, week 6 2026
Feb 9, 2026 07:00AM Prospect Enhanced Yield Fund, a Debt-Focused Structured Credit Interval Fund, Announces 10.6% Net Annualized 3-Month Total Return and 9.0% Cash Dividend Yield (on Net Asset Value) on Fully Deployed An
Feb 9, 2026 06:59AM Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knock-off Wegovy® and Ozempic®
View Newer Stories View Older Stories